标题
Diagnosis and Treatment of Multiple Sclerosis
作者
关键词
-
出版物
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
Volume 325, Issue 8, Pages 765
出版商
American Medical Association (AMA)
发表日期
2021-02-24
DOI
10.1001/jama.2020.26858
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Diroximel Fumarate Demonstrates an Improved Gastrointestinal Tolerability Profile Compared with Dimethyl Fumarate in Patients with Relapsing–Remitting Multiple Sclerosis: Results from the Randomized, Double-Blind, Phase III EVOLVE-MS-2 Study
- (2020) Robert T. Naismith et al. CNS DRUGS
- Change in pregnancy-associated multiple sclerosis relapse rates over time: a meta-analysis
- (2020) Ruth Dobson et al. Multiple Sclerosis and Related Disorders
- Ofatumumab versus Teriflunomide in Multiple Sclerosis
- (2020) Stephen L. Hauser et al. NEW ENGLAND JOURNAL OF MEDICINE
- Safety and efficacy of MD1003 (high-dose biotin) in patients with progressive multiple sclerosis (SPI2): a randomised, double-blind, placebo-controlled, phase 3 trial
- (2020) Bruce A C Cree et al. LANCET NEUROLOGY
- Association of Initial Disease-Modifying Therapy With Later Conversion to Secondary Progressive Multiple Sclerosis
- (2019) J. William L. Brown et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Effect of Nonmyeloablative Hematopoietic Stem Cell Transplantation vs Continued Disease-Modifying Therapy on Disease Progression in Patients With Relapsing-Remitting Multiple Sclerosis
- (2019) Richard K. Burt et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- The prevalence of MS in the United States
- (2019) Mitchell T. Wallin et al. NEUROLOGY
- Intracerebral haemorrhage during alemtuzumab administration
- (2019) Christina J Azevedo et al. LANCET NEUROLOGY
- Safety and efficacy of opicinumab in patients with relapsing multiple sclerosis (SYNERGY): a randomised, placebo-controlled, phase 2 trial
- (2019) Diego Cadavid et al. LANCET NEUROLOGY
- Pain Management in Multiple Sclerosis: a Review of Available Treatment Options
- (2019) Talal Aboud et al. Current Treatment Options in Neurology
- Safety and efficacy of ozanimod versus interferon beta-1a in relapsing multiple sclerosis (RADIANCE): a multicentre, randomised, 24-month, phase 3 trial
- (2019) Jeffrey A Cohen et al. LANCET NEUROLOGY
- Safety and efficacy of ozanimod versus interferon beta-1a in relapsing multiple sclerosis (SUNBEAM): a multicentre, randomised, minimum 12-month, phase 3 trial
- (2019) Giancarlo Comi et al. LANCET NEUROLOGY
- Infection Risks Among Patients With Multiple Sclerosis Treated With Fingolimod, Natalizumab, Rituximab, and Injectable Therapies
- (2019) Gustavo Luna et al. JAMA Neurology
- Therapeutic Apheresis in Acute Relapsing Multiple Sclerosis: Current Evidence and Unmet Needs—A Systematic Review
- (2019) Rolfes et al. Journal of Clinical Medicine
- Predictors of relapse and disability progression in MS patients who discontinue disease-modifying therapy
- (2018) Ilya Kister et al. JOURNAL OF THE NEUROLOGICAL SCIENCES
- Siponimod versus placebo in secondary progressive multiple sclerosis (EXPAND): a double-blind, randomised, phase 3 study
- (2018) Ludwig Kappos et al. LANCET
- Diagnosis of multiple sclerosis: 2017 revisions of the McDonald criteria
- (2018) Alan J Thompson et al. LANCET NEUROLOGY
- Psychiatric comorbidity is associated with disability progression in multiple sclerosis
- (2018) Kyla A. McKay et al. NEUROLOGY
- Phase I Trial of Intrathecal Mesenchymal Stem Cell-derived Neural Progenitors in Progressive Multiple Sclerosis
- (2018) Violaine K. Harris et al. EBioMedicine
- Application of the 2017 Revised McDonald Criteria for Multiple Sclerosis to Patients With a Typical Clinically Isolated Syndrome
- (2018) Roos M. van der Vuurst de Vries et al. JAMA Neurology
- The frequency of dysphagia and its impact on adults with multiple sclerosis based on patient-reported questionnaires
- (2018) Dalal Alali et al. Multiple Sclerosis and Related Disorders
- Clemastine fumarate as a remyelinating therapy for multiple sclerosis (ReBUILD): a randomised, controlled, double-blind, crossover trial
- (2017) Ari J Green et al. LANCET
- Alemtuzumab CARE-MS II 5-year follow-up
- (2017) Alasdair J. Coles et al. NEUROLOGY
- Ocrelizumab versus Interferon Beta-1a in Relapsing Multiple Sclerosis
- (2017) Stephen L. Hauser et al. NEW ENGLAND JOURNAL OF MEDICINE
- Unknown
- (2016) ANNALS OF NEUROLOGY
- Discontinuing disease-modifying therapy in MS after a prolonged relapse-free period: a propensity score-matched study
- (2016) Ilya Kister et al. JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY
- Targeting demyelination and virtual hypoxia with high-dose biotin as a treatment for progressive multiple sclerosis
- (2016) Frédéric Sedel et al. NEUROPHARMACOLOGY
- Unknown
- (2016) BIRTH DEFECTS RESEARCH PART A-CLINICAL AND MOLECULAR TERATOLOGY
- Unknown
- (2015) ANNALS OF NEUROLOGY
- Oral versus intravenous high-dose methylprednisolone for treatment of relapses in patients with multiple sclerosis (COPOUSEP): a randomised, controlled, double-blind, non-inferiority trial
- (2015) Emmanuelle Le Page et al. LANCET
- Multiple sclerosis and pregnancy in the 'treatment era'
- (2015) Sandra Vukusic et al. Nature Reviews Neurology
- Effect of comorbidity on mortality in multiple sclerosis
- (2015) Ruth Ann Marrie et al. NEUROLOGY
- Autologous hematopoietic stem cell transplantation in multiple sclerosis: A phase II trial
- (2015) G. L. Mancardi et al. NEUROLOGY
- Cardiorespiratory fitness and brain volume and white matter integrity: The CARDIA Study
- (2015) N. Zhu et al. NEUROLOGY
- High-Dose Immunosuppressive Therapy and Autologous Hematopoietic Cell Transplantation for Relapsing-Remitting Multiple Sclerosis (HALT-MS)
- (2015) Richard A. Nash et al. JAMA Neurology
- Association of Vitamin D Levels With Multiple Sclerosis Activity and Progression in Patients Receiving Interferon Beta-1b
- (2015) Kathryn C. Fitzgerald et al. JAMA Neurology
- B Cells in the Multiple Sclerosis Central Nervous System: Trafficking and Contribution to CNS-Compartmentalized Inflammation
- (2015) Laure Michel et al. Frontiers in Immunology
- The Underdiagnosis of Sleep Disorders in Patients with Multiple Sclerosis
- (2014) Steven D. Brass et al. Journal of Clinical Sleep Medicine
- Pegylated interferon beta-1a for relapsing-remitting multiple sclerosis (ADVANCE): a randomised, phase 3, double-blind study
- (2014) Peter A Calabresi et al. LANCET NEUROLOGY
- Oral teriflunomide for patients with relapsing multiple sclerosis (TOWER): a randomised, double-blind, placebo-controlled, phase 3 trial
- (2014) Christian Confavreux et al. LANCET NEUROLOGY
- Risk factors for multiple sclerosis, neuromyelitis optica and transverse myelitis
- (2014) KC Simon et al. Multiple Sclerosis Journal
- Brain reserve and cognitive reserve protect against cognitive decline over 4.5 years in MS
- (2014) J. F. Sumowski et al. NEUROLOGY
- Atlas of Multiple Sclerosis 2013: A growing global problem with widespread inequity
- (2014) P. Browne et al. NEUROLOGY
- MRI lesions as a surrogate for relapses in multiple sclerosis: a meta-analysis of randomised trials
- (2013) Maria Pia Sormani et al. LANCET NEUROLOGY
- Childhood body mass index and multiple sclerosis risk: a long-term cohort study
- (2013) Kassandra L Munger et al. Multiple Sclerosis Journal
- Effects of exercise on fitness and cognition in progressive MS: a randomized, controlled pilot trial
- (2013) S Briken et al. Multiple Sclerosis Journal
- Fine-Mapping the Genetic Association of the Major Histocompatibility Complex in Multiple Sclerosis: HLA and Non-HLA Effects
- (2013) Nikolaos A. Patsopoulos et al. PLoS Genetics
- Management options in multiple sclerosis-associated fatigue
- (2012) Maria Pia Amato et al. EXPERT OPINION ON PHARMACOTHERAPY
- Breastfeeding and multiple sclerosis relapses: a meta-analysis
- (2012) Julia Pakpoor et al. JOURNAL OF NEUROLOGY
- Alemtuzumab versus interferon beta 1a as first-line treatment for patients with relapsing-remitting multiple sclerosis: a randomised controlled phase 3 trial
- (2012) Jeffrey A Cohen et al. LANCET
- Alemtuzumab for patients with relapsing multiple sclerosis after disease-modifying therapy: a randomised controlled phase 3 trial
- (2012) Alasdair J Coles et al. LANCET
- Placebo-Controlled Phase 3 Study of Oral BG-12 or Glatiramer in Multiple Sclerosis
- (2012) Robert J. Fox et al. NEW ENGLAND JOURNAL OF MEDICINE
- Placebo-Controlled Phase 3 Study of Oral BG-12 for Relapsing Multiple Sclerosis
- (2012) Ralf Gold et al. NEW ENGLAND JOURNAL OF MEDICINE
- Risk of Natalizumab-Associated Progressive Multifocal Leukoencephalopathy
- (2012) Gary Bloomgren et al. NEW ENGLAND JOURNAL OF MEDICINE
- Meningeal inflammation is widespread and linked to cortical pathology in multiple sclerosis
- (2011) Owain W. Howell et al. BRAIN
- Sleep disturbances in multiple sclerosis
- (2011) Ana Caminero et al. JOURNAL OF THE NEUROLOGICAL SCIENCES
- Sun exposure and vitamin D are independent risk factors for CNS demyelination
- (2011) R. M. Lucas et al. NEUROLOGY
- Inflammatory Cortical Demyelination in Early Multiple Sclerosis
- (2011) Claudia F. Lucchinetti et al. NEW ENGLAND JOURNAL OF MEDICINE
- Randomized Trial of Oral Teriflunomide for Relapsing Multiple Sclerosis
- (2011) Paul O'Connor et al. NEW ENGLAND JOURNAL OF MEDICINE
- Smoking and Multiple Sclerosis: An Updated Meta-Analysis
- (2011) Adam E. Handel et al. PLoS One
- The natural history of multiple sclerosis, a geographically based study 10: relapses and long-term disability
- (2010) Antonio Scalfari et al. BRAIN
- Vascular comorbidity is associated with more rapid disability progression in multiple sclerosis
- (2010) R. A. Marrie et al. NEUROLOGY
- A Placebo-Controlled Trial of Oral Cladribine for Relapsing Multiple Sclerosis
- (2010) Gavin Giovannoni et al. NEW ENGLAND JOURNAL OF MEDICINE
- A Placebo-Controlled Trial of Oral Fingolimod in Relapsing Multiple Sclerosis
- (2010) Ludwig Kappos et al. NEW ENGLAND JOURNAL OF MEDICINE
- Oral Fingolimod or Intramuscular Interferon for Relapsing Multiple Sclerosis
- (2010) Jeffrey A. Cohen et al. NEW ENGLAND JOURNAL OF MEDICINE
- An Updated Meta-Analysis of Risk of Multiple Sclerosis following Infectious Mononucleosis
- (2010) Adam E. Handel et al. PLoS One
- The relation between inflammation and neurodegeneration in multiple sclerosis brains
- (2009) Josa M. Frischer et al. BRAIN
- The burden of mental comorbidity in multiple sclerosis: frequent, underdiagnosed, and undertreated
- (2009) RA Marrie et al. Multiple Sclerosis Journal
- Lifetime and actual prevalence of pain and headache in multiple sclerosis
- (2008) F Martinelli Boneschi et al. Multiple Sclerosis Journal
- Prevalence of sleep problems in individuals with multiple sclerosis
- (2008) AM Bamer et al. Multiple Sclerosis Journal
- Smoking worsens the prognosis in multiple sclerosis
- (2008) P Sundström et al. Multiple Sclerosis Journal
- Comorbidity delays diagnosis and increases disability at diagnosis in MS
- (2008) R. A. Marrie et al. NEUROLOGY
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now